Down-regulation of ALKBH2 increases cisplatin sensitivity in H1299 lung cancer cells

AIM: To elucidate the combined effect of alkylated DNA repair protein alkB homolog 2 (ALKBH2)-targeting gene therapy and cisplatin (cDDP) chemotherapy on the non-small cell lung cancer (NSCLC) H1299 cell line

Bibliographic Details
Published in:Acta pharmacologica Sinica, Vol. 32, No. 3 (2011), p. 393-8
Main Author: Wu, Shuang-shuang
Other Involved Persons: Xu, Wei ; Liu, Shan ; Chen, Bo ; Wang, Xue-li ; Wang, Yan ; Liu, Shi-feng ; Wu, Jian-qing
Format: electronic Article
Language:English
ISSN:1745-7254
Item Description:Date Completed 29.09.2011
Date Revised 21.02.2019
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
DOI:10.1038/aps.2010.216
Subjects:
QR Code: Show QR Code